Tacrolimus Dose Variability, CYP3A5 Genotype, and Acute Rejection in African American and European American Kidney Transplant Recipients

Stephan R. Seibert, D. Schladt, B. Wu, W. Guan, C. Dorr, D. Berglund, R. Remmel, A. Matas, R. Mannon, A. Israni

Research output: Contribution to conferencePaper

Original languageEnglish (US)
Pages732
Number of pages1
StatePublished - 2017

Cite this

Tacrolimus Dose Variability, CYP3A5 Genotype, and Acute Rejection in African American and European American Kidney Transplant Recipients. / Seibert, Stephan R.; Schladt, D.; Wu, B.; Guan, W.; Dorr, C.; Berglund, D.; Remmel, R.; Matas, A.; Mannon, R.; Israni, A.

2017. 732.

Research output: Contribution to conferencePaper

@conference{eeab5418c3c743a2a208893533ac5a0a,
title = "Tacrolimus Dose Variability, CYP3A5 Genotype, and Acute Rejection in African American and European American Kidney Transplant Recipients",
author = "Seibert, {Stephan R.} and D. Schladt and B. Wu and W. Guan and C. Dorr and D. Berglund and R. Remmel and A. Matas and R. Mannon and A. Israni",
year = "2017",
language = "English (US)",
pages = "732",

}

TY - CONF

T1 - Tacrolimus Dose Variability, CYP3A5 Genotype, and Acute Rejection in African American and European American Kidney Transplant Recipients

AU - Seibert, Stephan R.

AU - Schladt, D.

AU - Wu, B.

AU - Guan, W.

AU - Dorr, C.

AU - Berglund, D.

AU - Remmel, R.

AU - Matas, A.

AU - Mannon, R.

AU - Israni, A.

PY - 2017

Y1 - 2017

M3 - Paper

SP - 732

ER -